Posted on 5 月 15, 20255/15/25
From Science to Value: Strategic Asset Valuation for Biotech Licensing and Fundraising
Posted on 5 月 1, 20255/1/25
Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success
Posted on 4 月 1, 20254/1/25
Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth
Posted on 3 月 21, 20253/21/25
Capital Efficient Commercialization: A New Model for Success
Posted on 3 月 21, 20253/21/25
Boosting Pharma Efficiency: A New Model for Asset Value Retention
Posted on 3 月 2, 20253/2/25
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success
Posted on 2 月 21, 20252/21/25
Transformative Commercialization for New Biopharma Entrants: Ensuring Success With Capital and Time Efficiency
Posted on 12 月 4, 202412/4/24
Successfully Navigating Global Commercialization- A View from the C-Suite and Global Commercial Leaders
Posted on 11 月 12, 202411/12/24
Finding the Human Element Amid the Algorithms
Posted on 10 月 15, 202410/15/24